About Terns Pharmaceuticals, Inc. 
Terns Pharmaceuticals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 40 Schemes (22.96%)
Foreign Institutions
Held by 75 Foreign Institutions (14.21%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-24 Million
Pharmaceuticals & Biotechnology
USD 637 Million ()
NA (Loss Making)
NA
0.00%
-1.03
-30.06%
2.09






